AzTrials
AzTrials

Pregnancy RelatedNCT03705741

The Efficacy of Light-to-moderate Resistance Training in Sedentary Pregnant Women

A study testing Resistance exercise in people with Pregnancy Related and Sedentary Lifestyle, run by Värmland County Council, Sweden at 1 site in Sweden.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Maintaining a physically active lifestyle is associated with many health benefits, including lower risk of cardiovascular disease, diabetes, hypertension, some type of cancer, and depression . Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy Related, Sedentary Lifestyle
What is being tested?
Resistance exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteSweden
Study dates
5 Nov 2018to 15 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Single pregnancy and ≥18 of age
  • Ability to understand verbal and written Swedish

Who cannot join

  • Follows the recommendation regarding contraindications according to the American Collage of Obstetricians and Gynecologists 2002
  • Severe pain from the pelvic or the back
  • Regular exercise >150 minutes per week the last six months

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Fysioterapimottagningen Gripen

    Karlstad, 65224

Other trials in Sweden

About this study

Official title: The Efficacy of Light-to-moderate Resistance Training in Sedentary Pregnant Women: a Randomized Controlled Study

Maintaining a physically active lifestyle is associated with many health benefits, including lower risk of cardiovascular disease, diabetes, hypertension, some type of cancer, and depression . Pregnant, healthy women are recommended to do 30 minutes or more of light to moderate exercise a day, although most women in the Western world do not follow current recommendations and decrease their exercise level.

Benefits of exercise during pregnancy are several, including a protective effect against the development of gestational diabetes mellitus, reduced pregnancy related low back pain, and risk of caesarean delivery. On the contrary, a recent review concludes that sedentary behaviors are associated with higher levels of C Reactive Protein and LDL Cholesterol, a larger newborn abdominal circumference, and macrosomia.

Read more

Previous studies show that exercise during pregnancy is associated with improvements in psychological well-being among previously sedentary women.

Only a few RCT's have studied resistance exercise during pregnancy. These studies have found reduced fatigue and reduced need of insulin among women with gestational diabetes mellitus who did resistance exercise, with no adverse effects on fetus or the pregnant woman.

The aim of this study is to evaluate the efficacy of regular light -to-moderate resistance exercise among sedentary pregnant woman, with regard to fatigue, health related quality of life, pain location and intensity, body weight gain, blood pressure, and childbirth outcomes.

Being tested
Resistance exercise
Keywords
pregnancy, exercise, public health, randomized controlled trial
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance exerciseBehavioural

    Resistance exercise twice a week during pregnancy week 23-34.

Study groups in NCT03705741
Study groupRoleWhat they receive
Exercise groupExperimentalResistance exercise twice a week
Receives: Behavioral: Resistance exercise
Control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in fatigue

    Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure self-reported fatigue from 0, "no fatigue" to 100, "very great fatigue". The scale is a streight horizontal line.

    Measured: Register at gestational week 22 and 34

Secondary outcomes (12)
  1. Change in anxiety / depression

    Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure self-reported anxiety/depression from 0, "no anxiety/depression" to 100, "very great anxiety/depression". The scale is a streight horizontal line.

    Measured: Register at gestational week 22 and 34

  2. Change in pain

    Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure the intensity of pain from 0, "none pain" to 100, "extreme amount of pain". The scale is a streight horizontal line.

    Measured: Register at gestational week 22 and 34

  3. Change in Health Related Quality of Life

    Visual Analogue Scale (EQ-VAS). Mark health status on the day on a 20 centimeters vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine".

    Measured: Register at gestational week 22 and 34

  4. Change in blood pressure

    Systolic and Diastolic

    Measured: From perinatal records. Registered at gestational week 22 and 34

  5. Change in weight gain

    kilogram

    Measured: from perinatal records. Registered at gestational week 22 and 34

  6. Gestational Diabetes Mellitus (GDM)

    Development of GDM

    Measured: from perinatal records. Registered at gestational week 34

  7. Change in exercise

    Minutes a day. (Walks, light, moderate, vigorous intensity).

    Measured: Registered at gestational week 22 and 34

  8. Birth weight

    kilogram

    Measured: from perinatal records at birth (gestational week 40)

  9. Birth length

    centimeters

    Measured: from perinatal records at birth (gestational week 40)

  10. Gestational age

    days

    Measured: From perinatal records at birth (gestational week 40)

  11. Acute cesarean section

    rate

    Measured: from perinatal records at birth (gestational week 40)

  12. Macrosomia

    rate of birth with macrosomia

    Measured: from perinatal records at birth (gestational week 40)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2018
  2. Study start5 Nov 2018
  3. Primary completion15 Apr 2025
  4. Study completion15 Apr 2025

Why it stopped: Covid-19 In summary, 48 persons were included.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03705741
Sponsor's protocol ID
2018/246
Status last verified
Sep 2023
First submitted
3 Oct 2018
Last updated
17 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Resistance exercise in people with Pregnancy Related and Sedentary Lifestyle, run by Värmland County Council, Sweden at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Covid-19 In summary, 48 persons were included.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in fatigue (time frame: Register at gestational week 22 and 34). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in